Screening first-degree relatives for celiac disease: who, when and how often
Short answer
Guidelines from the American College of Gastroenterology (ACG), NICE and the British Society of Gastroenterology (BSG) name first-degree relatives of a person with celiac disease as people to test or screen1, 2, 3. They word the role of symptoms differently1, 4 and say little about how often to repeat the test6, 12.
- Who: parents, siblings and children are first-degree relatives7; the BSG’s 2026 update lists them among the groups to screen3.
- First test: a tTG-IgA antibody blood test, with a check of total IgA8, 9.
- Before any diet change: antibody tests need the person to be eating gluten54, and NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing10.
- How often: no common interval. The BSG’s 2026 text says one IgA-tTG, repeated if suspicion develops12; the ACG lists the best interval as an open research question6; the Celiac Disease Foundation gives its own figures13.
Part of Celiac genetics and family risk, 15 guides

Key points
- The documents word symptoms differently: the 2014 BSG guideline names symptomatic relatives4, while the ACG says a relative of a confirmed case should be tested whether or not signs or symptoms show1.
- The US Preventive Services Task Force (2017) found inadequate evidence on targeted screening of people at increased risk, family history included84.
- Risk figures differ by study and by relationship: 7.5% pooled prevalence in one meta-analysis14, 7% biopsy-confirmed in a later one15.
- ESPGHAN’s 2020 guideline for children lists first-degree relatives in its Table 216 and states no repeat interval17.
- A relative who has already cut out gluten faces a different path: the BSG describes 3–6 g of gluten daily for at least 6 weeks before testing19, and NICE refers people unable to reintroduce gluten to a specialist79.
Who counts as a first-degree relative
The Celiac Disease Foundation names parents, siblings and children as first-degree relatives of a person with celiac disease7. Coeliac UK lists the same people when it speaks of close relatives: father, mother, son, daughter, brother and sister20.
Celiac disease runs in families, but in a way that is not predictable, says Coeliac UK21. NIDDK puts it as a higher chance of developing the disease if someone in your family has it22. Our guide to whether celiac disease is hereditary covers the genetics.
On more distant relatives, the ACG says a lower rate probably applies to second-degree relatives, and that in a family with more than one person already identified, recommendations for screening should extend to all other family members, second-degree relatives included23.
What each guideline says about relatives
Each row is one document, with its year where it gives one. The wording is the document’s own; this page does not blend them into one rule.
| Source | What it says about first-degree relatives |
|---|---|
| ACG guideline update, 202324 | Relatives of a confirmed case “should be tested whether they show possible signs or symptoms or laboratory evidence of CD”; the next key concept says to consider testing asymptomatic relatives1, 5. |
| BSG adult guideline, 2026 | Advises screening for celiac disease in high-risk groups25; first-degree relatives are one of the four groups it names3. |
| BSG adult guideline, 201426 | Recommends testing people with suggested symptoms or syndromes, “especially if they have a first-degree relative with CD”27, and says symptomatic first-degree relatives should undergo testing (Grade C)4. |
| NICE guideline NG20, 201528 | Lists first-degree relatives among the people to whom serological testing should be offered2. |
| ESPGHAN guideline for children, 202029 | Recommends considering testing in children and adolescents with the symptoms, signs and conditions in its Table 230; that table names first-degree relatives with celiac disease16. |
| NIDDK (NIH) | Says blood relatives of people with celiac disease should talk with their doctor about their chances of getting it, to see if they should be tested; it adds that doctors in the United States do not routinely screen people31. The page was last reviewed October 202032. |
| US Preventive Services Task Force, 201733 | Found inadequate evidence on the effectiveness of targeted screening in people at increased risk, such as those with a family history84. |
| Coeliac UK | “Anyone who has a close relative with coeliac disease should be tested.”20 |
| Celiac Disease Foundation | Lists first-degree relatives among the people who should get screened34. |
Two things stand out. The ACG’s own list holds a firm statement (relatives “should be tested”) and a softer one (“Consider testing of asymptomatic relatives”)1, 5. And the US task force concluded that the evidence is insufficient to assess the balance of benefits and harms of screening asymptomatic people35.
Do relatives need symptoms first?
The documents word it differently. The 2014 BSG guideline says symptomatic first-degree relatives should undergo testing4. The ACG says first-degree relatives of a confirmed case should be tested whether or not they show possible signs or symptoms1. The BSG’s 2026 update treats relatives as one of its screening groups3, and says screening should be performed in diseases and conditions where the prevalence of undiagnosed celiac disease is substantially higher than in the general population36.
Some relatives with celiac disease have no symptoms. The BSG notes that some people with celiac disease report no symptoms37. A 2024 meta-analysis found that 34% of first-degree relatives with celiac disease were asymptomatic38, and a 2026 single-centre study of relatives of children with celiac disease found no significant association between symptoms and a positive result at either of its two screenings39.
On the other side of the ledger, the ACG says screen-detected asymptomatic patients remain without symptoms after starting a gluten-free diet, that most patients identified through screening reported dietary adherence and better quality of life, and that a small proportion reported increased health-related anxiety after diagnosis40.
Telling relatives: the ACG says newly diagnosed patients should inform their first-degree family members of the potential increased risk and of the recommendation for testing41.
How common is celiac disease in relatives, and whose numbers are these?
The figures differ by study and by source, and the ACG itself says the estimates vary substantially42. Each is attributed below.
| Source | Figure it gives |
|---|---|
| ACG (2023) | One large US multicenter study showed a rate as low as 5% in first-degree and second-degree relatives; other studies, especially community-based ones, show up to 20% in siblings and 10% in other first-degree relatives42. |
| BSG (2014) | A high prevalence, 10%, among first-degree relatives43. |
| US Preventive Services Task Force (2017) | An estimated prevalence of 5% to 20% for people with a positive family history, first- or second-degree44. |
| Coeliac UK; Celiac Disease Foundation | Around 1 in 10 close relatives “will be at risk” (Coeliac UK)20; a 1 in 10 risk compared with 1 in 100 in the general population (Celiac Disease Foundation)7. |
| Singh and colleagues, meta-analysis (2015) | Pooled prevalence 7.5% in 10,252 first-degree relatives and 2.3% in 642 second-degree relatives; highest in siblings (8.9%), then offspring (7.9%), then parents (3.0%)14. |
| Karimzadhagh and colleagues, meta-analysis (2024) | Pooled seroprevalence 11% and biopsy-confirmed prevalence 7% in first-degree relatives15. |
By relationship, both meta-analyses put sisters and daughters highest. The 2015 analysis reports 1 in 7 for sisters, 1 in 8 for daughters, and 1 in 32 and 1 in 33 for mothers and fathers45; the 2024 analysis says 1 in 4 daughters, 1 in 7 sisters, 1 in 11 brothers, 1 in 16 sons and 1 in 20 fathers and mothers could be affected46. For brothers and sons the two differ: 1 in 16 brothers and 1 in 13 sons in 201545, 1 in 11 brothers and 1 in 16 sons in 202446.
These are group figures from studies of relatives, not a prediction for one person. The ACG says the precise risk is highest in monozygous twins, then HLA-matched siblings, siblings, and finally parents and children47.
The first test, and why gluten stays in the diet until it is done
The sources name the same first step, though each words it its own way:
- ACG: measure tTG-IgA while on a regular, gluten-containing diet, plus total IgA if the patient has not been tested for IgA deficiency8.
- BSG 2026: IgA-tTG antibodies as the first-line investigation48, and advises screening for selective IgA deficiency in patients with suspected celiac disease alongside it49.
- ESPGHAN 2020, for children: total IgA and TGA-IgA as initial screening in children with suspected celiac disease50.
- Celiac Disease Foundation: a tTG-IgA test plus an IgA antibody, so that the test is accurate9.
When total IgA is low, the ACG says an IgG-based serology should be measured51, and ESPGHAN says an IgG-based test should be the second step50. Our guides on IgA deficiency and testing and the celiac blood test go further.
Why the diet matters before the test
NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing, because the diet can affect test results10. NICE says to explain that any test is accurate only if a gluten-containing diet is eaten during the diagnostic process52, and to advise people not to start a gluten-free diet until a specialist confirms the diagnosis, even if a serological test is positive53. The BSG’s 2026 text lists eating gluten before testing as its first diagnosis recommendation11, and the Celiac Disease Foundation says the blood test is accurate only on a gluten-containing diet54.
Where a gene test fits
NIDDK describes a gene test for groups of gene variants called DQ2 and DQ885. It says a person without them is very unlikely to have celiac disease, and that having DQ2 or DQ8 alone does not mean a person has it55. More in our guide to the DQ2 and DQ8 genes.
On relatives, the sources split. The BSG’s 2014 guideline said HLA typing can be used to rule out celiac disease and minimise future testing in high-risk people, first-degree relatives given as the example (Grade B)56. ESPGHAN’s 2020 text recalls that its 2012 guideline recommended HLA typing in at-risk groups, and says HLA typing may be cost-effective in some other groups, first-degree relatives given as an example57.
The BSG’s 2026 update notes it is widely recommended that HLA typing not be used as an initial diagnostic test58. It names three scenarios where it may help exclude celiac disease: a gluten-free diet started before testing, celiac-like biopsy changes with negative serology, and suspected celiac disease that does not respond to a gluten-free diet59. First-degree relatives are not on that list. The ACG says HLA typing is not required for diagnosis in all cases but may help in selected situations, and that a negative result rules celiac disease out60.
The Celiac Disease Foundation goes further and recommends the genetic test in family members, especially children, to prevent future unnecessary testing61. For a relative who carries the genes, see our guides on a child who tests positive for the gene and gene carriers who never develop celiac disease.
How often to repeat the test: what each source says
What each source says about repeating the test:
| Source | What it says |
|---|---|
| ACG (2023) | Lists “what is the optimal serologic screening interval?” among its open future-research questions, alongside the rate of seroconversion across the life course in people at increased risk6. |
| BSG (2026) | A single IgA-tTG should be measured in the screening groups, and repeated if the patient develops clinical suspicion for celiac disease12. |
| NICE NG20 | Advise people who test negative, particularly first-degree relatives, that celiac disease may present with a wide range of symptoms, and that they should consult their healthcare professional if the listed symptoms arise or persist62. |
| ESPGHAN (2020) | States no repeat interval for first-degree relatives in the text read17. |
| Celiac Disease Foundation | Says it recommends screening gene-positive first-degree relatives every 3-5 years13. A later paragraph of the same page says a positive genetic test result calls for follow-up screening every 2-3 years, or immediately if symptoms develop63. These are the charity’s own figures, given in separate paragraphs. |
Two follow-up studies show that relatives who test negative at first can test positive later. In one 2026 single-centre study of relatives of children with celiac disease, 101 first-degree relatives who were seronegative at first screening were retested after a median of 3.0 years; 4 had new seropositivity, and all four had biopsy-confirmed celiac disease64. Its authors say repeat screening, particularly in relatives first screened during early childhood, may improve case detection65. In one 2014 study, 205 previously seronegative first-degree relatives were retested; eight had seroconverted, and in five of them mucosal abnormalities confirmed celiac disease66.
These are observations, not interval recommendations. The 2014 study’s authors call for further studies to establish a useful and cost-effective algorithm for follow-up of relatives67.
Children and adults in the same family
Two of these texts are split by age. ESPGHAN’s 2020 guideline covers children and adolescents30; the BSG’s 2026 guideline covers adult celiac disease68. For a child with normal IgA values for age, ESPGHAN names TGA-IgA as the initial test regardless of age69.
NICE says not to offer serological testing in infants before gluten has been introduced into the diet70. The Celiac Disease Foundation quotes the University of Chicago Celiac Disease Center: children at risk are generally screened at age 2 or 3, unless symptoms are seen beforehand71.
In the 2026 single-centre study above, three of the four newly identified cases were siblings who had been screened in early childhood72.
What a negative or a positive result leads to
Negative
The ACG’s text says a negative tTG-IgA in a patient without IgA deficiency has a high negative predictive value when the pretest probability is low or moderate, and that celiac disease can be considered adequately ruled out in that scenario73. NICE adds the advice for relatives to consult a healthcare professional if symptoms arise or persist62.
Positive
For adults, the BSG’s 2026 text says positive screening serology should be confirmed by histology before a diagnosis is made74, and that a positive IgA-tTG should be followed by referral into secondary care75. The ACG says patients with an elevated TTG IgA level should proceed to upper endoscopy with duodenal biopsy76.
For children, ESPGHAN says that if TGA-IgA is at least 10 times the upper limit of normal and the family agrees, a no-biopsy diagnosis may be applied, provided endomysial antibodies test positive in a second blood sample77. More in our guides on what a tTG-IgA result means and diagnosis in children without a biopsy.
If a relative has already cut out gluten
The Celiac Disease Foundation says antibody blood testing is not accurate for people already on a gluten-free diet78. The sources give different rules on gluten before testing:
- NICE: for people on a normal diet containing gluten, eat some gluten in more than 1 meal every day for at least 6 weeks before testing18. People who restricted gluten but are reluctant or unable to reintroduce it should be referred to a gastrointestinal specialist, with the explanation that a biopsy diagnosis may be difficult79.
- BSG 2026: for those who have already started a gluten-free diet, 3–6 g of gluten daily for at least 6 weeks is considered sufficient19.
- Celiac Disease Foundation: a minimum of 3–6 grams of gluten per day for 12 weeks80, supervised by a physician trained in celiac disease81.
Some sources put the gene test first for this group. The ACG says HLA testing is central for people who started a gluten-free diet before evaluation, and that with a compatible haplotype a gluten challenge can be offered82. The BSG says HLA genotyping, if available, should be considered before a gluten challenge, because it may avoid the challenge83. See our guide to the gluten challenge.
Questions people ask
Should my children be tested if I have celiac disease?
The documents above name first-degree relatives, children included, as people to test or screen: the ACG says relatives of a confirmed case should be tested1, NICE lists them among people to offer serological testing2, and ESPGHAN’s Table 2 names them for children16. The US task force found inadequate evidence on targeted screening of people at increased risk84. NIDDK says blood relatives should talk with their doctor about whether they should be tested31.
Can a gene test replace the blood test for relatives?
Gene results are used differently from antibody results. NIDDK says having DQ2 or DQ8 alone does not mean a person has celiac disease55, and the BSG’s 2026 text notes it is widely recommended that HLA typing not be used as an initial diagnostic test58. A negative result makes celiac disease very unlikely, says NIDDK55.
Does a negative result mean a relative will never develop celiac disease?
NICE advises people who test negative, particularly first-degree relatives, that celiac disease may present with a wide range of symptoms and that they should consult a healthcare professional if symptoms arise or persist62. In one 2026 study of relatives of children with celiac disease, 4 of 101 relatives who were seronegative at first screening had new seropositivity after a median of 3.0 years64.
More in Celiac genetics and family risk
Carrying a celiac gene: how often it leads to celiac disease and what changes the oddsHow often people with the celiac gene variants develop celiac disease, how a relative with it changes the odds, and what is proven or only suspected.
Is celiac disease hereditary? What runs in families and what does notWhat NIDDK and pooled studies report on inherited risk for celiac disease: the DQ2 and DQ8 genes, twin data, and how rates differ among relatives.
Celiac screening in type 1 diabetes, Down syndrome and Turner syndrome: what the guidelines sayWhat ADA, ISPAD, AAP, ESPGHAN and the Turner syndrome guideline say about celiac antibody tests: the first test, the age to start, and how often to repeat.
A positive celiac gene test in your child: what it means and what happens nextWhat a positive HLA (DQ2 or DQ8) result in a child means, why sources say gluten stays in the diet until testing, and what clinicians check next.
Celiac genetic testing: what HLA-DQ2 and DQ8 results can and cannot tell youWhat HLA-DQ2 and DQ8 typing checks for, how NIDDK, ACG, ESPGHAN and WGO read a negative or positive result, and where the guidelines place the test.
Gone gluten-free without testing: what an HLA gene test can settleWhat an HLA-DQ2/DQ8 gene test can and cannot settle if you stopped gluten before celiac testing, and what sources say a gluten challenge involves.
Related guides
Celiac Blood Tests: What tTG-IgA, Total IgA, DGP and EMA Each CheckWhat tTG-IgA, total IgA, EMA and DGP check, why total IgA is drawn with tTG-IgA, when back-up tests are used, and why gluten stays in the diet first.
Celiac disease symptoms in children, and who pediatric guidelines say to testTypical and less typical celiac signs in children, who pediatric guidelines say to test, and why the child keeps eating gluten until testing ends.
Going gluten-free as a family: choose the household rule, then fix the kitchenAll gluten-free, shared with rules or split: what NIDDK, the charities and one small study say, plus rules for siblings and visiting relatives.
Type 1 diabetes and celiac disease: the overlap and the screening guidelinesWhy celiac disease is more common with type 1 diabetes, what the ADA, ISPAD and ACG say about screening and timing, and what to ask the care team.
Sources
- [1, 5, 6, 8, 23, 40, 41, 42, 47, 51, 60, 73, 76, 82] American College of Gastroenterology (Am J Gastroenterol), ACG Guidelines Update: Diagnosis and Management of Celiac Disease, checked Nov 17, 2026.
- [2, 18, 28, 52, 53, 62, 70, 79] National Institute for Health and Care Excellence (NICE), Coeliac disease: recognition, assessment and management (NG20), Recommendations, checked Nov 17, 2026.
Read on 2026-11-17: recommendation 1.1.1, “Offer serological testing for coeliac disease to: people with any of the following”, ends its list of symptoms and conditions with “first‑degree relatives of people with coeliac disease”.
Read on 2026-11-17: the page header names this “NICE guideline”, reference number NG20, “Published: 02 September 2015”.
- [3, 11, 12, 19, 25, 36, 37, 48, 49, 58, 59, 68, 74, 75, 83] British Society of Gastroenterology (Gut), The 2026 BSG guidelines on the diagnosis and management of adult coeliac disease, checked Nov 17, 2026.
- [4, 27, 43, 56] British Society of Gastroenterology (Gut), Diagnosis and management of adult coeliac disease: guidelines from the BSG (2014, full text), checked Nov 17, 2026.
- [7, 9, 13, 34, 54, 61, 63, 71, 78, 80, 81] Celiac Disease Foundation, Celiac Disease Screening, checked Nov 17, 2026.
Read on 2026-11-17: under the heading “Who should get screened?”, the second item of the list is “First-degree relatives of people with celiac disease – parents, siblings and children have a 1 in 10 risk compared to 1 in 100 in the general population”.
- [10, 31, 32, 55, 85] NIDDK (National Institutes of Health), Diagnosis of Celiac Disease, checked Nov 17, 2026.
- [14, 45] Singh et al., Am J Gastroenterol, Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: meta-analysis (2015), checked Nov 17, 2026.
- [15, 38, 46] Karimzadhagh et al., Am J Gastroenterol, Global Prevalence and Clinical Manifestations of Celiac Disease Among First-Degree Relatives: meta-analysis (2024), checked Nov 17, 2026.
- [16, 17, 30, 50, 57, 69] ESPGHAN (J Pediatr Gastroenterol Nutr), ESPGHAN Guidelines for Diagnosing Coeliac Disease 2020 (PDF), checked Nov 17, 2026.
Read on 2026-11-17: Table 2, “Symptoms and signs suggesting coeliac disease”, has a column headed “Specific conditions” whose list names first-degree relatives with CD; autoimmune conditions (T1DM, thyroid disease, liver disease); Down syndrome and Turner syndrome; Williams-Beuren syndrome; and IgA deficiency.
Searched the full text on 2026-11-17 for “interval”, “periodic”, “yearly”, “annual” and “every” followed by a number: the guideline states no repeat-testing interval for first-degree relatives.
- [20, 21] Coeliac UK, Screening for coeliac, checked Nov 17, 2026.
- [22] NIDDK (National Institutes of Health), Celiac Disease: Definition and Facts, checked Nov 17, 2026.
- [24] American College of Gastroenterology (Am J Gastroenterol), ACG Guidelines Update: Diagnosis and Management of Celiac Disease (PubMed record, 2023), checked Nov 17, 2026.
- [26] British Society of Gastroenterology (Gut), Diagnosis and management of adult coeliac disease: guidelines from the BSG (PubMed record, 2014), checked Nov 17, 2026.
- [29, 77] ESPGHAN (J Pediatr Gastroenterol Nutr), ESPGHAN Guidelines for Diagnosing Coeliac Disease 2020 (PubMed abstract), checked Nov 17, 2026.
- [33, 35, 44, 84] US Preventive Services Task Force, Celiac Disease: Screening, final recommendation statement, checked Nov 17, 2026.
- [39, 64, 65, 72] Teke et al., J Clin Pract Res, Second Screening for Celiac Disease in First-Degree Relatives of Pediatric Index Cases: A Single-Center Observational Study (2026), checked Nov 17, 2026.
- [66, 67] Uenishi et al., BMC Gastroenterol, Screening for celiac disease in 1st degree relatives: a 10-year follow-up study (2014), checked Nov 17, 2026.